Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

SUMO1-dependent modulation of SERCA2a in heart failure


The calcium-transporting ATPase ATP2A2, also known as SERCA2a, is a critical ATPase responsible for Ca2+ re-uptake during excitation–contraction coupling. Impaired Ca2+ uptake resulting from decreased expression and reduced activity of SERCA2a is a hallmark of heart failure1. Accordingly, restoration of SERCA2a expression by gene transfer has proved to be effective in improving cardiac function in heart-failure patients2, as well as in animal models3. The small ubiquitin-related modifier (SUMO) can be conjugated to lysine residues of target proteins4, and is involved in many cellular processes5. Here we show that SERCA2a is SUMOylated at lysines 480 and 585 and that this SUMOylation is essential for preserving SERCA2a ATPase activity and stability in mouse and human cells. The levels of SUMO1 and the SUMOylation of SERCA2a itself were greatly reduced in failing hearts. SUMO1 restitution by adeno-associated-virus-mediated gene delivery maintained the protein abundance of SERCA2a and markedly improved cardiac function in mice with heart failure. This effect was comparable to SERCA2A gene delivery. Moreover, SUMO1 overexpression in isolated cardiomyocytes augmented contractility and accelerated Ca2+ decay. Transgene-mediated SUMO1 overexpression rescued cardiac dysfunction induced by pressure overload concomitantly with increased SERCA2a function. By contrast, downregulation of SUMO1 using small hairpin RNA (shRNA) accelerated pressure-overload-induced deterioration of cardiac function and was accompanied by decreased SERCA2a function. However, knockdown of SERCA2a resulted in severe contractile dysfunction both in vitro and in vivo, which was not rescued by overexpression of SUMO1. Taken together, our data show that SUMOylation is a critical post-translational modification that regulates SERCA2a function, and provide a platform for the design of novel therapeutic strategies for heart failure.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Endogenous SUMO1 protein levels are decreased in both experimental animal and human heart failure.
Figure 2: SUMO1 is conjugated to lysines 480 and 585 of SERCA2a and is required for SERCA2a function.
Figure 3: SUMO1 overexpression restores TAC-induced cardiac dysfunction.
Figure 4: Reduction of SUMO1 levels accelerates cardiac dysfunction.


  1. Meyer, M. et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92, 778–784 (1995)

    CAS  Article  Google Scholar 

  2. Jessup, M. et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124, 304–313 (2011)

    CAS  Article  Google Scholar 

  3. Kawase, Y. et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J. Am. Coll. Cardiol. 51, 1112–1119 (2008)

    CAS  Article  Google Scholar 

  4. Johnson, E. S. Protein modification by SUMO. Annu. Rev. Biochem. 73, 355–382 (2004)

    CAS  Article  Google Scholar 

  5. Geiss-Friedlander, R. & Melchior, F. Concepts in sumoylation: a decade on. Nature Rev. Mol. Cell Biol. 8, 947–956 (2007)

    CAS  Article  Google Scholar 

  6. Adachi, T. et al. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nature Med. 10, 1200–1207 (2004)

    CAS  Article  Google Scholar 

  7. Knyushko, T. V., Sharov, V. S., Williams, T. D., Schoneich, C. & Bigelow, D. J. 3-Nitrotyrosine modification of SERCA2a in the aging heart: a distinct signature of the cellular redox environment. Biochemistry 44, 13071–13081 (2005)

    CAS  Article  Google Scholar 

  8. Sampson, D. A., Wang, M. & Matunis, M. J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276, 21664–21669 (2001)

    CAS  Article  Google Scholar 

  9. Plemper, R. K. & Wolf, D. H. Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem. Sci. 24, 266–270 (1999)

    CAS  Article  Google Scholar 

  10. Schillinger, W., Fiolet, J. W., Schlotthauer, K. & Hasenfuss, G. Relevance of Na+-Ca2+exchange in heart failure. Cardiovasc. Res. 57, 921–933 (2003)

    CAS  Article  Google Scholar 

  11. Wang, J., Feng, X. H. & Schwartz, R. J. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity. J. Biol. Chem. 279, 49091–49098 (2004)

    CAS  Article  Google Scholar 

  12. Matsuzaki, K. et al. Serum response factor is modulated by the SUMO-1 conjugation system. Biochem. Biophys. Res. Commun. 306, 32–38 (2003)

    CAS  Article  Google Scholar 

  13. Wang, J. & Schwartz, R. J. Sumoylation and regulation of cardiac gene expression. Circ. Res. 107, 19–29 (2010)

    CAS  Article  Google Scholar 

  14. Brady, M. et al. Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes. Cardiovasc. Res. 60, 347–354 (2003)

    ADS  CAS  Article  Google Scholar 

  15. Vlasblom, R. et al. Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes. Cardiovasc. Res. 63, 537–544 (2004)

    CAS  Article  Google Scholar 

  16. Drewett, V. et al. Serum response factor cleavage by caspases 3 and 7 linked to apoptosis in human BJAB cells. J. Biol. Chem. 276, 33444–33451 (2001)

    CAS  Article  Google Scholar 

  17. Okura, T. et al. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157, 4277–4281 (1996)

    CAS  PubMed  Google Scholar 

  18. Baba, D. et al. Crystal structure of thymine DNA glycosylase conjugated to SUMO-1. Nature 435, 979–982 (2005)

    ADS  CAS  Article  Google Scholar 

  19. Van Rechem, C. et al. Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells. Mol. Cell. Biol. 30, 4045–4059 (2010)

    CAS  Article  Google Scholar 

  20. Choudhary, C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834–840 (2009)

    ADS  CAS  Article  Google Scholar 

  21. Kim, M. J., Chia, I. V. & Costantini, F. SUMOylation target sites at the C terminus protect axin from ubiquitination and confer protein stability. FASEB J. 22, 3785–3794 (2008)

    CAS  Article  Google Scholar 

  22. Mooney, S. M., Grande, J. P., Salisbury, J. L. & Janknecht, R. Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry 49, 1–10 (2010)

    CAS  Article  Google Scholar 

  23. Ryu, K. Y., Garza, J. C., Lu, X. Y., Barsh, G. S. & Kopito, R. R. Hypothalamic neurodegeneration and adult-onset obesity in mice lacking the Ubb polyubiquitin gene. Proc. Natl Acad. Sci. USA 105, 4016–4021 (2008)

    ADS  CAS  Article  Google Scholar 

  24. Hajjar, R. J., Schmidt, U., Kang, J. X., Matsui, T. & Rosenzweig, A. Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca2+-ATPase. Circ. Res. 81, 145–153 (1997)

    CAS  Article  Google Scholar 

  25. Lee, A. Y. et al. Identification of the degradome of Isp-1, a major intracellular serine protease of Bacillus subtilis, by two-dimensional gel electrophoresis and matrix- assisted laser desorption/ionization-time of flight analysis. Proteomics 4, 3437–3445 (2004)

    CAS  Article  Google Scholar 

  26. Jeong, D. et al. PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility. Circ. Res. 99, 307–314 (2006)

    CAS  Article  Google Scholar 

  27. Zolotukhin, S. et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973–985 (1999)

    CAS  Article  Google Scholar 

  28. Kizana, E., Cingolani, E. & Marban, E. Non-cell-autonomous effects of vector-expressed regulatory RNAs in mammalian heart cells. Gene Ther. 16, 1163–1168 (2009)

    CAS  Article  Google Scholar 

  29. Tiscornia, G., Singer, O., Ikawa, M. & Verma, I. M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl Acad. Sci. USA 100, 1844–1848 (2003)

    ADS  CAS  Article  Google Scholar 

  30. Hajjar, R. J. et al. Modulation of ventricular function through gene transfer in vivo . Proc. Natl Acad. Sci. USA 95, 5251–5256 (1998)

    ADS  CAS  Article  Google Scholar 

  31. Pacher, P., Nagayama, T., Mukhopadhyay, P., Batkai, S. & Kass, D. A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nature Protocols 3, 1422–1434 (2008)

    CAS  Article  Google Scholar 

  32. Porterfield, J. E. et al. Dynamic correction for parallel conductance, GP, and gain factor, α, in invasive murine left ventricular volume measurements. J. Appl. Physiol. 107, 1693–1703 (2009)

    Article  Google Scholar 

Download references


This work is supported by NIH RO1 HL083156, HL080498, HL093183 and P20HL100396 (R.J.H.). W.J.P. is funded by Global Research Laboratory Program (M6-0605-00-0001) of the Korean Ministry of Science and Technology.

Author information

Authors and Affiliations



C.K., A.L. and R.J.H. conceived the project and its design. C.K., A.L., D.J., J.G.O. and A.H.C. performed experiments and data analysis. E.K. aided in experimental design. C.K., A.L., W.J.P. and R.J.H. wrote the manuscript.

Corresponding author

Correspondence to Roger J. Hajjar.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

The file contains Supplementary Figures 1-11 with legends and Supplementary Tables 1-9. (PDF 9783 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kho, C., Lee, A., Jeong, D. et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature 477, 601–605 (2011).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing